{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T01:38:30Z","timestamp":1789609110254,"version":"build-2803163510"},"reference-count":61,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["trasci.com","clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion and Apheresis Science"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.transci.2024.104036","type":"journal-article","created":{"date-parts":[[2024,11,23]],"date-time":"2024-11-23T02:48:53Z","timestamp":1732330133000},"page":"104036","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Evaluating the safety and efficacy of plasma therapy\/plasmapheresis for systemic sclerosis \u2013 A comprehensive systematic review"],"prefix":"10.1016","volume":"64","author":[{"given":"Saira","family":"Bano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inshal","family":"Jawed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad umair","family":"abdul qadir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed Ali Farhan","family":"Abbas Rizvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikash Kumar","family":"Karmani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farah","family":"Alam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul","family":"Haseeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hina","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agha Muhammad Wali","family":"Mirza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naheed","family":"Akhtar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abu Huraira","family":"Bin Gulzar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khabab Abbasher","family":"Hussien Mohamed Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.transci.2024.104036_bib1","first-page":"1867","article-title":"Increased prevalence of scleroderma in southwestern Ontario: a cluster analysis","volume":"29","author":"Thompson","year":"2002","journal-title":"J Rheumatol"},{"issue":"3","key":"10.1016\/j.transci.2024.104036_bib2","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/MD.0b013e3181dde28d","article-title":"Group CSR. Systemic sclerosis: establishing diagnostic criteria","volume":"89","author":"Hudson","year":"2010","journal-title":"Medicine"},{"issue":"10373","key":"10.1016\/j.transci.2024.104036_bib3","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S0140-6736(22)01692-0","article-title":"Systemic sclerosis","volume":"401","author":"Volkmann","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.transci.2024.104036_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2023.109267","article-title":"Global, regional, and national incidence and prevalence of systemic sclerosis","volume":"248","author":"Tian","year":"2023","journal-title":"Clin Immunol"},{"issue":"3","key":"10.1016\/j.transci.2024.104036_bib5","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2021-001694","article-title":"All-cause mortality in systemic rheumatic diseases under treatment compared with the general population, 2015-2019","volume":"7","author":"Bournia","year":"2021","journal-title":"RMD Open"},{"issue":"7","key":"10.1016\/j.transci.2024.104036_bib6","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1093\/rheumatology\/kez486","article-title":"Racial differences in systemic sclerosis disease presentation: a European Scleroderma Trials and Research group study","volume":"59","author":"Jaeger","year":"2020","journal-title":"Rheumatol (Oxf)"},{"issue":"2","key":"10.1016\/j.transci.2024.104036_bib7","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/MD.0000000000000018","article-title":"Early- versus late-onset systemic sclerosis: differences in clinical presentation and outcome in 1037 patients","volume":"93","author":"Alba","year":"2014","journal-title":"Med (Baltim)"},{"issue":"8","key":"10.1016\/j.transci.2024.104036_bib8","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1007\/s10067-024-07025-z","article-title":"Late-age onset systemic sclerosis-clinical and serological characteristics","volume":"43","author":"Wielosz","year":"2024","journal-title":"Clin Rheuma"},{"issue":"1","key":"10.1016\/j.transci.2024.104036_bib9","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1186\/s13075-018-1771-0","article-title":"Prevalence of comorbidities in systemic sclerosis versus rheumatoid arthritis: a comparative, multicenter, matched-cohort study","volume":"20","author":"Panopoulos","year":"2018","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"10.1016\/j.transci.2024.104036_bib10","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/rheumatology\/keq321","article-title":"Late-onset systemic sclerosis--a systematic survey of the EULAR scleroderma trials and research group database","volume":"50","author":"H\u00fcgle","year":"2011","journal-title":"Rheumatol (Oxf)"},{"issue":"11","key":"10.1016\/j.transci.2024.104036_bib11","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","article-title":"2013 classification criteria for systemic sclerosis: an American college of rheumatology\/European league against rheumatism collaborative initiative","volume":"72","author":"van den Hoogen","year":"2013","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.transci.2024.104036_bib12","doi-asserted-by":"crossref","first-page":"55","DOI":"10.7861\/clinmedicine.16-1-55","article-title":"Advances in pathogenesis and treatment of systemic sclerosis","volume":"16","author":"Denton","year":"2016","journal-title":"Clin Med (Lond)"},{"issue":"7","key":"10.1016\/j.transci.2024.104036_bib13","first-page":"1573","article-title":"Criteria for the classification of early systemic sclerosis","volume":"28","author":"LeROY","year":"2001","journal-title":"J Rheumatol"},{"issue":"5","key":"10.1016\/j.transci.2024.104036_bib14","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1177\/0885066610371181","article-title":"Analytic review: care of patients with scleroderma in the intensive care setting","volume":"25","author":"Farber","year":"2010","journal-title":"J Intensive care Med"},{"key":"10.1016\/j.transci.2024.104036_bib15","series-title":"Seminars in arthritis and rheumatism","article-title":"Consortium PmotSCT, Group CSR, editors. Treatment of systemic sclerosis complications: what to use when first-line treatment fails\u2014a consensus of systemic sclerosis experts","author":"Walker","year":"2012"},{"issue":"9","key":"10.1016\/j.transci.2024.104036_bib16","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/j.1346-8138.1992.tb03722.x","article-title":"Clinical comments and a pathophysiological discussion of scleroderma","volume":"19","author":"LeRoy","year":"1992","journal-title":"J Dermatol"},{"issue":"3","key":"10.1016\/j.transci.2024.104036_bib17","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/j.1365-2133.1992.tb00648.x","article-title":"Analysis of collagen gene expression by cultured fibroblasts in morphoea","volume":"126","author":"Hatamochi","year":"1992","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.transci.2024.104036_bib18","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/j.1365-2133.1992.tb00450.x","article-title":"Increased expression of tenascin in the dermis in scleroderma","volume":"127","author":"Lacour","year":"1992","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.transci.2024.104036_bib19","first-page":"791","article-title":"Extracellular microfibrils are increased in localized and systemic scleroderma skin","volume":"64","author":"Fleischmajer","year":"1991","journal-title":"Lab Investig; a J Tech Methods Pathol"},{"issue":"3","key":"10.1016\/j.transci.2024.104036_bib20","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0190-9622(88)70070-5","article-title":"Systemic scleroderma: clinical and pathophysiologic aspects","volume":"18","author":"Krieg","year":"1988","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.transci.2024.104036_bib21","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1111\/1523-1747.ep12560826","article-title":"Identification of fibroblasts responsible for increased collagen production in localized scleroderma by in situ hybridization","volume":"90","author":"K\u00e4h\u00e4ri","year":"1988","journal-title":"J Invest Dermatol"},{"issue":"1","key":"10.1016\/j.transci.2024.104036_bib22","doi-asserted-by":"crossref","DOI":"10.1186\/ar4486","article-title":"Association of anti-RNA polymerase III autoantibodies and cancer in scleroderma","volume":"16","author":"Moinzadeh","year":"2014","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"10.1016\/j.transci.2024.104036_bib23","doi-asserted-by":"crossref","first-page":"S181","DOI":"10.5152\/eurjrheum.2020.19131","article-title":"A. Putative functional pathogenic autoantibodies in systemic sclerosis","volume":"7","author":"Benfaremo","year":"2020","journal-title":"Eur J Rheuma"},{"issue":"4","key":"10.1016\/j.transci.2024.104036_bib24","doi-asserted-by":"crossref","DOI":"10.1111\/micc.12447","article-title":"Automated assessment of absolute nailfold capillary number on videocapillaroscopic images: Proof of principle and validation in systemic sclerosis","volume":"25","author":"Cutolo","year":"2018","journal-title":"Microcirculation"},{"issue":"7","key":"10.1016\/j.transci.2024.104036_bib25","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1177\/039139889201500710","article-title":"Lung involvement in systemic sclerosis sine scleroderma treated by plasma exchange","volume":"15","author":"Ferri","year":"1992","journal-title":"Int J Artif Organs"},{"issue":"6","key":"10.1016\/j.transci.2024.104036_bib26","first-page":"900","article-title":"Fulminant thrombotic thrombocytopenic purpura in a patient with the limited form of scleroderma: successful outcome using plasma exchange","volume":"18","author":"Cookson","year":"1991","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.transci.2024.104036_bib27","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1177\/039139889001300213","article-title":"Treatment of progressive systemic sclerosis by plasma exchange: long-term results in 40 patients","volume":"13","author":"Guillevin","year":"1990","journal-title":"Int J Artif Organs"},{"issue":"8","key":"10.1016\/j.transci.2024.104036_bib28","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1093\/qjmed\/hcm052","article-title":"Scleroderma renal crisis: patient characteristics and long-term outcomes","volume":"100","author":"Penn","year":"2007","journal-title":"QJM: Int J Med"},{"issue":"3","key":"10.1016\/j.transci.2024.104036_bib29","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S2213-2600(19)30480-1","article-title":"Systemic sclerosis-associated interstitial lung disease","volume":"8","author":"Perelas","year":"2020","journal-title":"Lancet Respir Med"},{"issue":"4","key":"10.1016\/j.transci.2024.104036_bib30","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s11926-014-0411-1","article-title":"Recent advances in understanding the pathogenesis of scleroderma-interstitial lung disease","volume":"16","author":"Akter","year":"2014","journal-title":"Curr Rheuma Rep"},{"issue":"2","key":"10.1016\/j.transci.2024.104036_bib31","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/1529-0131(200102)44:2<474::AID-ANR67>3.0.CO;2-#","article-title":"Blockade of endogenous transforming growth factor \u03b2 signaling prevents up-regulated collagen synthesis in scleroderma fibroblasts: association with increased expression of transforming growth factor \u03b2 receptors","volume":"44","author":"Ihn","year":"2001","journal-title":"Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.transci.2024.104036_bib32","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1136\/annrheumdis-2011-200955","article-title":"Clinical and pathological significance of interleukin 6 overexpression in systemic sclerosis","volume":"71","author":"Khan","year":"2012","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.transci.2024.104036_bib33","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1164\/rccm.200806-953OC","article-title":"Connective tissue disease\u2013associated pulmonary arterial hypertension in the modern treatment era","volume":"179","author":"Condliffe","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.transci.2024.104036_bib34","doi-asserted-by":"crossref","DOI":"10.1136\/ard.2005.048967","article-title":"Bosentan therapy for pulmonary arterial hypertension related to connective tissue disease: a subgroup analysis of the pivotal clinical trials and their open-label extensions","author":"Denton","year":"2006","journal-title":"Ann Rheum Dis"},{"issue":"_3","key":"10.1016\/j.transci.2024.104036_bib35","doi-asserted-by":"crossref","first-page":"iii45","DOI":"10.1093\/rheumatology\/kep110","article-title":"Cardiac complications of systemic sclerosis","volume":"48","author":"Kahan","year":"2006","journal-title":"Rheumatology"},{"issue":"11","key":"10.1016\/j.transci.2024.104036_bib36","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1093\/rheumatology\/kel120","article-title":"Angiographically proven coronary artery disease in scleroderma","volume":"45","author":"Akram","year":"2006","journal-title":"Rheumatology"},{"issue":"6","key":"10.1016\/j.transci.2024.104036_bib37","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/00002281-199611000-00012","article-title":"Gastrointestinal features of scleroderma","volume":"8","author":"Sjogren","year":"1996","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.transci.2024.104036_bib38","doi-asserted-by":"crossref","DOI":"10.1136\/ard.2006.066068","article-title":"Changes in causes of death in systemic sclerosis, 1972-2002","author":"Steen","year":"2007","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.transci.2024.104036_bib39","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.berh.2009.12.002","article-title":"Evidence-based management of rapidly progressing systemic sclerosis","volume":"24","author":"Khanna","year":"2010","journal-title":"Best Pr Res Clin Rheuma"},{"issue":"3","key":"10.1016\/j.transci.2024.104036_bib40","article-title":"Antifibrotics in systemic sclerosis","volume":"35","author":"Martin-Lopez","year":"2021","journal-title":"Best Pr Res Clin Rheuma"},{"issue":"26","key":"10.1016\/j.transci.2024.104036_bib41","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1056\/NEJMoa1903076","article-title":"Nintedanib for systemic sclerosis\u2013associated interstitial lung disease","volume":"380","author":"Distler","year":"2019","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.transci.2024.104036_bib42","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S2213-2600(20)30036-9","article-title":"Nintedanib in patients with progressive fibrosing interstitial lung diseases\u2014subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial","volume":"8","author":"Wells","year":"2020","journal-title":"Lancet Respir Med"},{"issue":"2","key":"10.1016\/j.transci.2024.104036_bib43","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3109\/10408368609165798","article-title":"Therapeutic plasmapheresis and plasma exchange","volume":"23","author":"Patten","year":"1986","journal-title":"Crit Rev Clin Lab Sci"},{"key":"10.1016\/j.transci.2024.104036_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijsu.2021.105906","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"88","author":"Page","year":"2021","journal-title":"Int J Surg"},{"issue":"1","key":"10.1016\/j.transci.2024.104036_bib45","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3233\/CH-1985-5112","article-title":"Plasmapheresis as a treatment of raynaud-attacks: microrheological differential diagnosis and evaluation of efficacy","volume":"5","author":"Weber","year":"1985","journal-title":"Clin Hemorheol Microcirc"},{"issue":"2","key":"10.1016\/j.transci.2024.104036_bib46","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0278-6222(87)80026-8","article-title":"Plasma exchange in the treatment of progressive systemic sclerosis","volume":"8","author":"Ferri","year":"1987","journal-title":"Plasma Ther Transfus Technol"},{"issue":"6","key":"10.1016\/j.transci.2024.104036_bib47","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1177\/039139888300600608","article-title":"Treatment of progressive systemic sclerosis with plasma exchange. Seven cases","volume":"6","author":"Guillevin","year":"1983","journal-title":"Int J Artif Organs"},{"issue":"4","key":"10.1016\/j.transci.2024.104036_bib48","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/jca.2920030406","article-title":"Plasma exchange in the treatment of nonadvanced stages of progressive systemic sclerosis","volume":"3","author":"Mascaro","year":"1987","journal-title":"J Clin Apher"},{"issue":"12","key":"10.1016\/j.transci.2024.104036_bib49","doi-asserted-by":"crossref","first-page":"4398","DOI":"10.1093\/ndt\/gfs317","article-title":"Prognosis of scleroderma renal crisis: a long-term observational study","volume":"27","author":"Cozzi","year":"2012","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"10.1016\/j.transci.2024.104036_bib50","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3233\/CH-1985-5111","article-title":"Plasma filtration in patients with Raynaud\u2019s phenomenon","volume":"5","author":"Von Rhede van der Kloot","year":"1985","journal-title":"Clin Hemorheol Microcirc"},{"issue":"4","key":"10.1016\/j.transci.2024.104036_bib51","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/jca.2920010404","article-title":"Plasma exchange: a controlled study of the effect in patients with Raynaud's phenomenon and scleroderma","volume":"1","author":"McCune","year":"1983","journal-title":"J Clin Apher"},{"issue":"6171","key":"10.1016\/j.transci.2024.104036_bib52","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1136\/bmj.1.6171.1113","article-title":"Controlled trial of plasma exchange in treatment of Raynaud's syndrome","volume":"1","author":"O'Reilly","year":"1979","journal-title":"Br Med J"},{"issue":"2","key":"10.1016\/j.transci.2024.104036_bib53","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0278-6222(87)80018-9","article-title":"Plasma exchange therapy in progressive systemic sclerosis","volume":"8","author":"Pourrat","year":"1987","journal-title":"Plasma Ther Transfus Technol"},{"issue":"2","key":"10.1016\/j.transci.2024.104036_bib54","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3233\/CH-16140","article-title":"Successful long-term (22 year) treatment of limited scleroderma using therapeutic plasma exchange: Is blood rheology the key?","volume":"65","author":"Harris","year":"2017","journal-title":"Clin Hemorheol Microcirc"},{"issue":"5","key":"10.1016\/j.transci.2024.104036_bib55","doi-asserted-by":"crossref","first-page":"649","DOI":"10.2169\/internalmedicine.31.649","article-title":"A successful therapy with plasma exchange for interstitial pneumonia of progressive systemic sclerosis","volume":"31","author":"Tamura","year":"1992","journal-title":"Intern Med"},{"issue":"4","key":"10.1016\/j.transci.2024.104036_bib56","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/j.1365-2133.1995.tb02713.x","article-title":"Treatment of severe localized scleroderma by plasmapheresis report of three cases","volume":"133","author":"Wach","year":"1995","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.transci.2024.104036_bib57","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1445-5994.1987.tb01237.x","article-title":"Acute scleroderma in stable mixed connective tissue disease: treatment by plasmapheresis","volume":"17","author":"Crapper","year":"1987","journal-title":"Aust NZ J Med"},{"key":"10.1016\/j.transci.2024.104036_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.coph.2022.102211","article-title":"Current advances in the treatment of systemic sclerosis","volume":"64","author":"Bukiri","year":"2022","journal-title":"Curr Opin Pharmacol"},{"issue":"18","key":"10.1016\/j.transci.2024.104036_bib59","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0197-1859(81)80066-0","article-title":"Treatment of childhood mixed connective tissue disease with plasmapheresis","volume":"2","author":"Hertzman","year":"1981","journal-title":"Clin Immunol Newsl"},{"issue":"4","key":"10.1016\/j.transci.2024.104036_bib60","first-page":"133","article-title":"Plasma exchange in progressive systemic sclerosis","volume":"2","author":"Owlia","year":"2015","journal-title":"Am J Exp Clin Res"},{"issue":"2","key":"10.1016\/j.transci.2024.104036_bib61","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1177\/2397198318758606","article-title":"Therapeutic plasma exchange for the treatment of systemic sclerosis: a comprehensive review and analysis","volume":"3","author":"Harris","year":"2018","journal-title":"J Scleroderma Relat Disord"}],"container-title":["Transfusion and Apheresis Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050224002179?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050224002179?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T08:48:12Z","timestamp":1738572492000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1473050224002179"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":61,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S1473050224002179"],"URL":"https:\/\/doi.org\/10.1016\/j.transci.2024.104036","relation":{},"ISSN":["1473-0502"],"issn-type":[{"value":"1473-0502","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluating the safety and efficacy of plasma therapy\/plasmapheresis for systemic sclerosis \u2013 A comprehensive systematic review","name":"articletitle","label":"Article Title"},{"value":"Transfusion and Apheresis Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transci.2024.104036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104036"}}